-
Something wrong with this record ?
The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke
V. Prochazka, T. Jonszta, D. Czerny, J. Krajca, M. Roubec, J. Macak, P. Kovar, P. Kovarova, M. Pulcer, R. Zoubkova, I. Lochman, V. Svachova, L. Pavliska, A. Vrtkova, D. Kasprak, J. Gumulec, JW. Weisel,
Language English Country United States
Document type Journal Article
NLK
PubMed Central
from 2011
Europe PubMed Central
from 2011
Open Access Digital Library
from 2011-01-01
Medline Complete (EBSCOhost)
from 2017-01-01
PubMed
29887594
DOI
10.12659/msm.908441
Knihovny.cz E-resources
- MeSH
- Cerebral Arteries metabolism pathology MeSH
- Stroke blood metabolism surgery MeSH
- Demography MeSH
- Blood Coagulation MeSH
- Brain Ischemia blood metabolism surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- ADAMTS13 Protein metabolism MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Thrombectomy * MeSH
- Thrombosis blood immunology metabolism MeSH
- von Willebrand Factor metabolism MeSH
- Treatment Outcome MeSH
- Inflammation pathology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND The aim of the study was to investigate the role of von Willebrand factor (vWF), the vWF-cleaving protease, ADAMTS13, the composition of thrombus, and patient outcome following mechanical cerebral artery thrombectomy in patients with acute ischemic stroke. MATERIAL AND METHODS A prospective cohort study included 131 patients with ischemic stroke (<6 hours) with or without intravenous thrombolysis. Interventional procedure parameters, hemocoagulation markers, vWF, ADAMTS13, and histological examination of the extracted thrombi were performed. The National Institutes of Health Stroke Scale (NIHSS) score was used on hospital admission, after 24 hours, at day 7; the three-month modified Rankin Scale score was used. RESULTS Mechanical thrombectomy resulted in a Treatment in Cerebral Ischemia (TICI) score of 2-3, with recanalization in 89% of patients. Intravenous thrombolysis was used in 101 (78%). Patients with and without intravenous thrombolysis therapy had a good clinical outcome (score 0-2) in 47% of cases (P=0.459) using the three-month modified Rankin Scale. Patients with a National Institutes of Health Stroke Scale (NIHSS) score ≥15 had significantly increased vWF levels (P=0.003), and a significantly increased vWF: ADAMTS13 ratio (P=0.038) on hospital admission. Significant correlation coefficients were found for plasma vWF and thrombo-embolus vWF (r=0.32), platelet (r=0.24), and fibrin (r=0.26) levels. In the removed thrombus, vWF levels were significantly correlated with platelet count (r=0.53), CD31-positive cells (r=0.38), and fibrin (r=0.48). CONCLUSIONS In patients with acute ischemic stroke, mechanical cerebral artery thrombectomy resulted in a good clinical outcome in 47% of cases, with and without intravenous thrombolysis therapy.
Blood Centre University Hospital Ostrava Ostrava Czech Republic
Department of Applied Mathematics VŠB Technical University of Ostrava Ostrava Czech Republic
Department of Clinical Hematology University Hospital Ostrava Ostrava Czech Republic
Department of Hematooncology University Hospital Ostrava Ostrava Czech Republic
Department of Neurology University Hospital Ostrava Ostrava Czech Republic
Department of Pathology University Hospital Ostrava Ostrava Czech Republic
Department of Radiology University Hospital Ostrava Ostrava Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000655
- 003
- CZ-PrNML
- 005
- 20210322135837.0
- 007
- ta
- 008
- 190107s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.12659/MSM.908441 $2 doi
- 035 __
- $a (PubMed)29887594
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Prochazka, Vaclav $u Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic.
- 245 14
- $a The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke / $c V. Prochazka, T. Jonszta, D. Czerny, J. Krajca, M. Roubec, J. Macak, P. Kovar, P. Kovarova, M. Pulcer, R. Zoubkova, I. Lochman, V. Svachova, L. Pavliska, A. Vrtkova, D. Kasprak, J. Gumulec, JW. Weisel,
- 520 9_
- $a BACKGROUND The aim of the study was to investigate the role of von Willebrand factor (vWF), the vWF-cleaving protease, ADAMTS13, the composition of thrombus, and patient outcome following mechanical cerebral artery thrombectomy in patients with acute ischemic stroke. MATERIAL AND METHODS A prospective cohort study included 131 patients with ischemic stroke (<6 hours) with or without intravenous thrombolysis. Interventional procedure parameters, hemocoagulation markers, vWF, ADAMTS13, and histological examination of the extracted thrombi were performed. The National Institutes of Health Stroke Scale (NIHSS) score was used on hospital admission, after 24 hours, at day 7; the three-month modified Rankin Scale score was used. RESULTS Mechanical thrombectomy resulted in a Treatment in Cerebral Ischemia (TICI) score of 2-3, with recanalization in 89% of patients. Intravenous thrombolysis was used in 101 (78%). Patients with and without intravenous thrombolysis therapy had a good clinical outcome (score 0-2) in 47% of cases (P=0.459) using the three-month modified Rankin Scale. Patients with a National Institutes of Health Stroke Scale (NIHSS) score ≥15 had significantly increased vWF levels (P=0.003), and a significantly increased vWF: ADAMTS13 ratio (P=0.038) on hospital admission. Significant correlation coefficients were found for plasma vWF and thrombo-embolus vWF (r=0.32), platelet (r=0.24), and fibrin (r=0.26) levels. In the removed thrombus, vWF levels were significantly correlated with platelet count (r=0.53), CD31-positive cells (r=0.38), and fibrin (r=0.48). CONCLUSIONS In patients with acute ischemic stroke, mechanical cerebral artery thrombectomy resulted in a good clinical outcome in 47% of cases, with and without intravenous thrombolysis therapy.
- 650 _2
- $a protein ADAMTS13 $x metabolismus $7 D000071120
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a hemokoagulace $7 D001777
- 650 _2
- $a ischemie mozku $x krev $x metabolismus $x chirurgie $7 D002545
- 650 _2
- $a arteriae cerebrales $x metabolismus $x patologie $7 D002536
- 650 _2
- $a demografie $7 D003710
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x patologie $7 D007249
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a cévní mozková příhoda $x krev $x metabolismus $x chirurgie $7 D020521
- 650 12
- $a trombektomie $7 D017131
- 650 _2
- $a trombóza $x krev $x imunologie $x metabolismus $7 D013927
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a von Willebrandův faktor $x metabolismus $7 D014841
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jonszta, Tomas $u Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Czerny, Daniel $u Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Krajca, Jan $u Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Roubec, Martin $u Department of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Macak, Jirka $u Department of Pathology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Kovar, Petr $u Department of Pathology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Kovarova, Petra $u Blood Centre, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Pulcer, Martin $u Department of Clinical Hematology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Zoubkova, Renata $u Department of Anesthesiology, Resuscitation and Intensive Medicine Clinic, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Lochman, Ivo $u SPADIA LAB Plc., Ostrava, Czech Republic.
- 700 1_
- $a Svachova, Veronika $u SPADIA LAB Plc., Ostrava, Czech Republic.
- 700 1_
- $a Pavliska, Lubomir $u Department of Deputy Director of Science and Research, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Vrtková, Adéla $u Department of Applied Mathematics , VŠB-Technical University of Ostrava, Ostrava, Czech Republic. $7 xx0258595
- 700 1_
- $a Kasprak, David $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Gumulec, Jaromir $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Weisel, John W $u Department of Cell and Developmental Biology, University of Pensylvania School of Medicine, Philadelphia, PA, USA.
- 773 0_
- $w MED00003251 $t Medical science monitor international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 24, č. - (2018), s. 3929-3945
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29887594 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20210322135751 $b ABA008
- 999 __
- $a ok $b bmc $g 1363890 $s 1038778
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 24 $c - $d 3929-3945 $e 20180611 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
- LZP __
- $a Pubmed-20190107